134 related articles for article (PubMed ID: 23748830)
21. Whole-Field Sequential Intensity-Modulated Radiotherapy for Local-Regional Advanced Head-and-Neck Squamous Cell Carcinoma.
Refaat T; Choi M; Thomas TO; Bacchus I; Agulnik M; Pelzer HJ; Mellott AL; Rademaker AW; Liu D; Sathiaseelan V; Mittal BB
Am J Clin Oncol; 2015 Dec; 38(6):588-94. PubMed ID: 24136140
[TBL] [Abstract][Full Text] [Related]
22. [Minor salivary gland tumors of the nasopharynx].
Li TS
Zhonghua Zhong Liu Za Zhi; 1990 Mar; 12(2):127-9. PubMed ID: 2169388
[TBL] [Abstract][Full Text] [Related]
23. [Primitive intracranial adenoid cystic carcinoma. A case report].
Kanouni L; Kebdani T; El Ghazi EA; El Mostarchid B; Amarti A; Mansouri A; Errihani H; Benjaafar N; El Gueddari BK
Neurochirurgie; 2003 Mar; 49(1):39-43. PubMed ID: 12736579
[TBL] [Abstract][Full Text] [Related]
24. Definitive intensity-modulated radiation therapy for nasopharyngeal carcinoma: long-term outcome of a multicenter prospective study.
Wang R; Wu F; Lu H; Wei B; Feng G; Li G; Liu M; Yan H; Zhu J; Zhang Y; Hu K
J Cancer Res Clin Oncol; 2013 Jan; 139(1):139-45. PubMed ID: 22986812
[TBL] [Abstract][Full Text] [Related]
25. The role of skull base surgery for the treatment of adenoid cystic carcinoma of the sinonasal tract.
Pitman KT; Prokopakis EP; Aydogan B; Segas J; Carrau RL; Snyderman CH; Janecka IP; Hanna E; D'Amico F; Johnson JT
Head Neck; 1999 Aug; 21(5):402-7. PubMed ID: 10402519
[TBL] [Abstract][Full Text] [Related]
26. Local regression and control of T1-2 nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.
Xue F; Ou D; Hu C; He X
Cancer Med; 2018 Dec; 7(12):6010-6019. PubMed ID: 30406969
[TBL] [Abstract][Full Text] [Related]
27. Combined intensity-modulated radiotherapy plus raster-scanned carbon ion boost for advanced adenoid cystic carcinoma of the head and neck results in superior locoregional control and overall survival.
Jensen AD; Nikoghosyan AV; Poulakis M; Höss A; Haberer T; Jäkel O; Münter MW; Schulz-Ertner D; Huber PE; Debus J
Cancer; 2015 Sep; 121(17):3001-9. PubMed ID: 26043145
[TBL] [Abstract][Full Text] [Related]
28. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience.
Sultanem K; Shu HK; Xia P; Akazawa C; Quivey JM; Verhey LJ; Fu KK
Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):711-22. PubMed ID: 11020568
[TBL] [Abstract][Full Text] [Related]
29. Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma: a retrospective controlled study.
Qiu WZ; Huang PY; Shi JL; Xia HQ; Zhao C; Cao KJ
Chin J Cancer; 2016 Jan; 35():2. PubMed ID: 26739148
[TBL] [Abstract][Full Text] [Related]
30. Cetuximab or nimotuzumab plus intensity-modulated radiotherapy versus cisplatin plus intensity-modulated radiotherapy for stage II-IVb nasopharyngeal carcinoma.
You R; Sun R; Hua YJ; Li CF; Li JB; Zou X; Yang Q; Liu YP; Zhang YN; Yu T; Cao JY; Zhang MX; Jiang R; Mo HY; Guo L; Cao KJ; Lin AH; Qian CN; Sun Y; Ma J; Chen MY
Int J Cancer; 2017 Sep; 141(6):1265-1276. PubMed ID: 28577306
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
[TBL] [Abstract][Full Text] [Related]
32. Complete response to radiation therapy for nasopharyngeal sarcomatoid carcinoma.
Lee MJ; Son HJ
J Cancer Res Ther; 2020; 16(3):653-656. PubMed ID: 32719284
[TBL] [Abstract][Full Text] [Related]
33. [Nasopharyngeal adenoid cystic carcinoma, a rare but highly challenging disease with unmet therapeutic needs: A case-report and review of the literature].
Afani L; Errihani H; Benchafai I; Lalami Y
Cancer Radiother; 2016 Jul; 20(5):400-4. PubMed ID: 27131394
[TBL] [Abstract][Full Text] [Related]
34. Concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: treatment outcomes of a prospective, multicentric clinical study.
Wu F; Wang R; Lu H; Wei B; Feng G; Li G; Liu M; Yan H; Zhu J; Zhang Y; Hu K
Radiother Oncol; 2014 Jul; 112(1):106-11. PubMed ID: 24933452
[TBL] [Abstract][Full Text] [Related]
35. Intensity-modulated radiation therapy without concurrent chemotherapy for stage IIb nasopharyngeal cancer.
Tham IW; Lin S; Pan J; Han L; Lu JJ; Wee J
Am J Clin Oncol; 2010 Jun; 33(3):294-9. PubMed ID: 20395788
[TBL] [Abstract][Full Text] [Related]
36. Adenoid cystic carcinoma of Bartholin's gland receiving adjuvant radiation therapy: case report.
Agolli L; Osti MF; Armosini V; De Sanctis V; Valeriani M; Enrici RM
Eur J Gynaecol Oncol; 2013; 34(5):487-8. PubMed ID: 24475591
[TBL] [Abstract][Full Text] [Related]
37. A Rare Nasopharyngeal Adenoid Cystic Carcinoma: Case Report and Literature Review.
Alsubaie NM; Alhussien A; Alghulikah A; Alabood S; Alsukayt M; Alarifi I
Am J Case Rep; 2023 Apr; 24():e938858. PubMed ID: 37002593
[TBL] [Abstract][Full Text] [Related]
38. Management of nasopharyngeal salivary gland malignancy.
Schramm VL; Imola MJ
Laryngoscope; 2001 Sep; 111(9):1533-44. PubMed ID: 11568602
[TBL] [Abstract][Full Text] [Related]
39. Neoadjuvant chemotherapy followed by concurrent chemoradiation for locally advanced nasopharyngeal carcinoma.
Kong L; Zhang YW; Hu CS; Guo Y
Chin J Cancer; 2010 May; 29(5):551-5. PubMed ID: 20426907
[TBL] [Abstract][Full Text] [Related]
40. Results of a combination treatment with intensity modulated radiotherapy and active raster-scanning carbon ion boost for adenoid cystic carcinoma of the minor salivary glands of the nasopharynx.
Akbaba S; Ahmed D; Lang K; Held T; Mattke M; Hoerner-Rieber J; Herfarth K; Rieken S; Plinkert P; Debus J; Adeberg S
Oral Oncol; 2019 Apr; 91():39-46. PubMed ID: 30926061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
